InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-4.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Reali Kenneth Michael, 董事长兼首席执行官. Director active across 1 company, notably Bioventus Inc.. Aggregated, 2 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 9 September 2021. The latest transaction was filed on 9 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reali Kenneth Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
28,721 股Class A Common StockSEC:0000899243-23-008792:0
1,800 股@ US$14.81100.0% 占其流量Class A Common StockSEC:0000899243-21-035518:0
标准退出：2021年12月8日 (T+90)
2 条申报中的 2 条
About Reali Kenneth Michael
Kenneth Michael Reali is the Chief Executive Officer of Bioventus Inc. As CEO, he leads the company and is responsible for overall strategy and operations. His leadership is essential for the development and growth of Bioventus. Kenneth Michael Reali has extensive experience in the medical sector, enabling him to make informed decisions to guide the company towards success.
